Roivant Sciences (ROIV) upgraded to Buy on strong Phase 2 BEACON data for brepocitinib; see pipeline upside, risks, and why ...

Mediated Chemotherapeutic Delivery and Reinforces its Potential to Provide Individualized, Optimized Drug-DeliveryMOUNTAIN ...

Key opportunities in the Bronchiectasis clinical trials market include leveraging comprehensive data on trial distribution by region, identifying cost-effective trial locations, assessing trial ...

By Kamal Choudhury and Sahil Pandey Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday defended its AI strategy against analyst concerns that recent technology ...

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall ...

The report highlights strategic insights into global Crohn's Disease clinical trials, emphasizing opportunities for investment and cost-efficient trial locations. It aids in formulating business ...

Credence Research Inc. announces the publication of its latest report on the Global Retail Pharmacy Market, which is projected to grow from USD 1,445.9 billion in 2024 to USD 1,965.9 billion by 2032, ...

Key market opportunities in cSCC clinical trials include identifying strategic investment areas, leveraging prominent trial locations to cut costs, and understanding trial success rates. The report's ...

Avalo Therapeutics completed Phase 2 enrollment for AVTX-009, with mid-2026 data ahead. Cantor sees major upside if results ...

Pfizer announces the first data from its Metsera-acquired pipeline just ahead of its earnings call, where analysts pressed ...

Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best stocks under $3 to invest in. On February 4, H.C. Wainwright analyst ...